.png)
Danny Kim, PharmD, Head of WELT USA, is a pharmacist by training and a builder at heart, powered by the mission to democratize healthcare through technologies that improve access to quality care.
Danny serves as a Board Member at Digital Therapeutics Alliance. He also serves as an advisor to the Korean government on matters involving digital health and digital therapeutics.
Before joining WELT, Danny worked with PillPack (acq. by Amazon), Pear Therapeutics (IPO '21), and invested in early-stage startups with Contrary. Danny continues to invest in early-stage healthcare companies through the Digital Health Partners, Korea's first venture fund dedicated to digital health, as an LP and an advisor.
Danny holds a B.S. Pharmacy Studies & Doctor of Pharmacy at Northeastern University where he serves as a Board Member of the HSE and a member of Young Global Leaders.
Danny serves as a Board Member at Digital Therapeutics Alliance. He also serves as an advisor to the Korean government on matters involving digital health and digital therapeutics.
Before joining WELT, Danny worked with PillPack (acq. by Amazon), Pear Therapeutics (IPO '21), and invested in early-stage startups with Contrary. Danny continues to invest in early-stage healthcare companies through the Digital Health Partners, Korea's first venture fund dedicated to digital health, as an LP and an advisor.
Danny holds a B.S. Pharmacy Studies & Doctor of Pharmacy at Northeastern University where he serves as a Board Member of the HSE and a member of Young Global Leaders.
Speaking In
1:00 PM - 2:00 PM
Monday, June 5
